Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer
- PMID: 27079212
- PMCID: PMC4877250
- DOI: 10.1016/j.ygyno.2016.04.001
Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer
Erratum in
-
Corrigendum to "Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer" [Gynecol. Oncol. 141 (2016) 588-591].Gynecol Oncol. 2016 Oct;143(1):224. doi: 10.1016/j.ygyno.2016.07.108. Epub 2016 Jul 28. Gynecol Oncol. 2016. PMID: 27477189 Free PMC article. No abstract available.
Abstract
Objectives: Small cell cervical cancer is a rare malignancy with limited treatment options for recurrent disease. We sought to determine if tumor specimens of small cell cervical cancer harbor common somatic mutations and if any of these are actionable.
Methods: Using a registry of patients with neuroendocrine cervical cancer, we identified 44 patients with pure or mixed small cell cervical cancer who had undergone mutational analysis. Mutations had been detected using next generation sequencing of mutational hotspots in 50 cancer-related genes.
Results: Thirty-five mutations were identified in 24 patients (55%). Fifteen of these 24 patients (63%) had 1 mutation, 7 patients (29%) had 2 mutations, and 2 patients (8%) had 3 mutations. In all 44 patients, the most commonly seen mutations were mutations in PIK3CA (8 patients; 18%), KRAS (6 patients; 14%), and TP53 (5 patients; 11%). No other mutation was found in >7% of specimens. Of the 24 patients who had a mutation, 21 (88%) had at least 1 alteration for which there currently exists a class of biological agents targeting that mutation. In the entire cohort of 44 patients, 48% had at least 1 actionable mutation.
Conclusion: Although no single mutation was found in the majority of patients with small cell cervical cancer, almost half had at least 1 actionable mutation. As treatment options for patients with recurrent small cell cervical cancer are currently very limited, molecular testing for targetable mutations, which may suggest potential therapeutic strategies, may be useful for clinicians and patients.
Keywords: Cervical cancer; Large cell; Neuroendocrine; Personalized medicine; Small cell; Somatic mutations.
Copyright © 2016 Elsevier Inc. All rights reserved.
Conflict of interest statement
Similar articles
-
Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.Am J Surg Pathol. 2018 Jun;42(6):750-760. doi: 10.1097/PAS.0000000000001042. Am J Surg Pathol. 2018. PMID: 29505425 Free PMC article.
-
Comparative genomics of high grade neuroendocrine carcinoma of the cervix.PLoS One. 2020 Jun 16;15(6):e0234505. doi: 10.1371/journal.pone.0234505. eCollection 2020. PLoS One. 2020. PMID: 32544169 Free PMC article.
-
Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.J Transl Med. 2015 Jul 25;13:244. doi: 10.1186/s12967-015-0611-0. J Transl Med. 2015. PMID: 26209091 Free PMC article.
-
Small Cell and Other Rare Histologic Types of Cervical Cancer.Curr Oncol Rep. 2022 Nov;24(11):1531-1539. doi: 10.1007/s11912-022-01316-x. Epub 2022 Aug 10. Curr Oncol Rep. 2022. PMID: 35947285 Review.
-
Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.Cancer Treat Rev. 2021 Jul;98:102225. doi: 10.1016/j.ctrv.2021.102225. Epub 2021 May 23. Cancer Treat Rev. 2021. PMID: 34082256 Free PMC article. Review.
Cited by
-
Advancements in the Understanding of Small-Cell Neuroendocrine Cervical Cancer: Where We Stand and What Lies Ahead.J Pers Med. 2024 Apr 27;14(5):462. doi: 10.3390/jpm14050462. J Pers Med. 2024. PMID: 38793044 Free PMC article. Review.
-
Pan-Canadian Analysis of Practice Patterns in Small Cell Carcinoma of the Cervix: Insights from a Multidisciplinary Survey.Curr Oncol. 2024 May 3;31(5):2610-2619. doi: 10.3390/curroncol31050196. Curr Oncol. 2024. PMID: 38785477 Free PMC article.
-
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.Clin Cancer Res. 2024 May 1;30(9):1846-1858. doi: 10.1158/1078-0432.CCR-23-2360. Clin Cancer Res. 2024. PMID: 38180245 Free PMC article.
-
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives.J Clin Med. 2023 Dec 15;12(24):7715. doi: 10.3390/jcm12247715. J Clin Med. 2023. PMID: 38137784 Free PMC article. Review.
-
Advances in Research, Diagnosis, and Treatment of Neuroendocrine Cervical Carcinoma: A Review.Oncol Rev. 2023 Nov 1;17:11764. doi: 10.3389/or.2023.11764. eCollection 2023. Oncol Rev. 2023. PMID: 38025893 Free PMC article. Review.
References
-
- Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–45. - PubMed
-
- Alfsen GC, Thoresen SO, Kristensen GB, Skovlund E, Abeler VM. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer. 2000;89:1291–9. - PubMed
-
- Chen J, Macdonald OK, Gaffney DK. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix. Obstet Gynecol. 2008;111:1394–402. - PubMed
-
- McCusker ME, Cote TR, Clegg LX, Tavassoli FJ. Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecol Oncol. 2003;88:333–9. - PubMed
-
- Wang KL, Chang TC, Jung SM, Chen CH, Cheng YM, Wu HH, Liou WS, Hsu ST, Ou YC, Yeh LS, Lai HC, Huang CY, Chen TC, Chang CJ, Lai CH. Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: a Taiwanese Gynecologic Oncology Group study. Eur J Cancer. 2012;48:1484–94. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous